SoftOx Solutions AS engages in research and product development. It intends to develop antiseptic agents to prevent and treat problematic skin infections with high-unmet needs and to help overcome the global challenge of antibiotic resistance with its novel solutions. The company was founded by Kristian Almas and Geir Hermod Almas on June 21, 2012 and is headquartered in Oslo, Norway.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company